{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:54:47Z","timestamp":1781603687736,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,6,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction::<\/jats:title>\n                    <jats:p>Flavone derivatives are naturally occurring compounds with diverse\nbiological activities, including anticancer effects. However, the anticancer potential\nof sulfonamide-substituted flavones remains largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods::<\/jats:title>\n                    <jats:p>Compounds 7a-7l were synthesized via Claisen-Schmidt condensation\nof N-(3-acetyl-4-hydroxyphenyl)acetamide with various aromatic aldehydes.\nStructural characterization was performed using 1H, 13C, and 19F NMR spectroscopy,\nLC-MS, and elemental analysis. Molecular docking was conducted using AutoDock Vina,\nwith input files prepared via AutoDockTools (ADT). The pharmacokinetic properties\nof compound 7f were predicted in silico using the PreADMET web tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results::<\/jats:title>\n                    <jats:p>Among the synthesized compounds, 7f exhibited the highest anticancer activity\nagainst the NCI-60 panel, with GI50 values ranging from 0.58 to 14.6 \u03bcM and total\ngrowth inhibition (TGI) values from 9.17 \u03bcM to &gt;100 \u03bcM. The strongest activity was\nobserved against leukemia (K-562, GI50 = 0.58 \u03bcM), melanoma (MDA-MB-435, GI50 =\n1.03 \u03bcM), renal (TK-10, GI50 = 1.08 \u03bcM; A498, GI50 = 1.88 \u03bcM), lung (HOP-92, GI50 =\n1.34 \u03bcM), and CNS (SNB-75, GI50 = 1.63 \u03bcM) cancer cell lines. Low cytotoxicity was\nobserved for most subpanels (LC50 &gt; 100 \u03bcM). Molecular docking analysis suggested poly(\nADP-ribose) polymerases (PARP1, TNKS1, and TNKS2) as potential molecular targets,\nwith TNKS1 exhibiting the most favorable binding affinity (\u0394G = -11.1 kcal\/mol).\nin silico ADME predictions indicated a favorable pharmacokinetic profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion::<\/jats:title>\n                    <jats:p>A series of sulfonamide-flavone hybrids was designed, synthesized, and\nevaluated using a combination of in vitro and in silico approaches. The results support\nthe flavone-sulfonamide scaffold as a viable platform for further anticancer drug development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion::<\/jats:title>\n                    <jats:p>In summary, twelve novel flavone-sulfonamide hybrids were successfully\nsynthesized and characterized. Biological evaluation identified compound 7f as the most\nactive derivative against the NCI-60 panel, exhibiting broad-spectrum anticancer activity\nwith low cytotoxicity. Molecular docking and ADME analyses further supported its\npotential, identifying compound 7f as a promising lead compound for further optimization.\nIncorporation of a sulfonamide group at the 6-position of the flavone scaffold resulted\nin an eightfold increase in anticancer activity (GI), from 7% for the flavone to\n55% for lead compound 7f.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673449251260504133036","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:35:12Z","timestamp":1781602512000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis and Biological Evaluation of Novel Flavone-Sulfonamide Hybrid Derivatives as Potential Anticancer Agents"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8464-3692","authenticated-orcid":true,"given":"Ivan","family":"Semenyuta","sequence":"first","affiliation":[{"name":"Department of Chemistry Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute ofBioorganic Chemistry and Petrochemistry, National Academy of Sciences of Ukraine, Kyiv, 02094,Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-601X","authenticated-orcid":true,"given":"Mykhaylo","family":"Frasinyuk","sequence":"additional","affiliation":[{"name":"1Department of Chemistry Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute ofBioorganic Chemistry and Petrochemistry, National Academy of Sciences of Ukraine, Kyiv, 02094,Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9429-3507","authenticated-orcid":true,"given":"Svitlana","family":"Bondarenko","sequence":"additional","affiliation":[{"name":"Department of Food Chemistry, National University of Food Technologies, Kyiv, 01601, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-3412","authenticated-orcid":true,"given":"Volodymyr","family":"Brovarets","sequence":"additional","affiliation":[{"name":"Department of Chemistry Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute ofBioorganic Chemistry and Petrochemistry, National Academy of Sciences of Ukraine, Kyiv, 02094,Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673449251260504133036","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/255008\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673449251260504133036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:35:19Z","timestamp":1781602519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/255008\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673449251260504133036","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}